Akebia Therapeutics
(AKBA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -69,410 | -51,925 | -94,226 | -282,024 | -384,841 |
| Depreciation Amortization | 41,702 | 41,846 | 37,697 | 37,955 | 149,070 |
| Accounts receivable | 4,046 | 994 | 11,297 | -24,027 | 11,669 |
| Other Working Capital | -39,676 | -20,727 | -1,443 | -105,611 | -12,855 |
| Other Operating Activity | 22,679 | 6,428 | -26,479 | 120,742 | 126,569 |
| Operating Cash Flow | $-40,659 | $-23,384 | $-73,154 | $-252,965 | $-110,388 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 40,000 | 60,245 |
| PPE Investments | -33 | N/A | -114 | -59 | -317 |
| Purchase Of Investment | N/A | N/A | N/A | 0 | -99,932 |
| Sale Of Investment | N/A | N/A | N/A | 40,000 | 60,245 |
| Other Investing Activity | 0 | 0 | 0 | -40,000 | -60,245 |
| Investing Cash Flow | $-33 | $N/A | $-114 | $39,941 | $-40,004 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 45,000 | N/A | -33,000 | 0 | 19,975 |
| Debt Repayment | -37,099 | -32,000 | N/A | 0 | 0 |
| Common Stock Issued | 43,034 | 6,794 | 7,598 | 88,948 | 211,745 |
| Other Financing Activity | -1,272 | 0 | 40,000 | 44,783 | 0 |
| Financing Cash Flow | $49,663 | $-25,206 | $14,598 | $133,731 | $231,720 |
| Beginning Cash Position | 44,579 | 93,169 | 151,839 | 231,132 | 149,804 |
| End Cash Position | 53,550 | 44,579 | 93,169 | 151,839 | 231,132 |
| Net Cash Flow | $8,971 | $-48,590 | $-58,670 | $-79,293 | $81,328 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,659 | -23,384 | -73,154 | -252,965 | -110,388 |
| Capital Expenditure | -33 | N/A | -114 | -59 | -317 |
| Free Cash Flow | -40,692 | -23,384 | -73,268 | -253,024 | -110,705 |